| scholarly article | Q13442814 |
| P356 | DOI | 10.1152/PHYSREV.1960.40.1.27 |
| P698 | PubMed publication ID | 13824830 |
| P2093 | author name string | E D FREIS | |
| P921 | main subject | hemodynamics | Q1642137 |
| hypertension | Q95566669 | ||
| P304 | page(s) | 27-54 | |
| P577 | publication date | 1960-01-01 | |
| P1433 | published in | Physiological Reviews | Q1091827 |
| P1476 | title | Hemodynamics of hypertension | |
| P478 | volume | 40 |
| Q72306785 | A Clinical Trial of Guanoxan (Envacar®) in Hypertension Resistant to Common Drugs |
| Q34449098 | A study of the antihypertensive action of xipamide using ambulatory intra‐arterial monitoring |
| Q54485527 | Acute haemodynamic effects of carvedilol (BM 14190), a new combined beta-adrenoceptor blocker and precapillary vasodilating agent, in hypertensive patients |
| Q79350240 | Adoptive transfer of transplantation immunity by means of blood-borne cells |
| Q36106916 | Alpha- and beta-adrenergic receptor blockade in the treatment of hypertension |
| Q34549430 | Arterial hemodynamics in human hypertension |
| Q36694441 | Autonomic nervous cardiovascular regulation in borderline hypertension |
| Q35537700 | Beta-adrenergic blockade in hypertension |
| Q36745405 | Cardiac rhythm in hypertension assessed through 24 hour ambulatory electrocardiographic monitoring. Effects of load manipulation with atenolol, verapamil, and nifedipine |
| Q72526521 | Cardiovascular effects of obesity and hypertension |
| Q39496534 | Cardiovascular pathophysiology of essential hypertension: a clue to therapy |
| Q78841662 | Cationic exchange and control of blood pressure |
| Q40347800 | Centrally induced hypotensive effects of β-adrenergic blocking drugs |
| Q43499370 | Combination therapy of essential hypertension with pindolol (Visken) and hydralazine |
| Q39581801 | Combined action drugs in the treatment of hypertension |
| Q46194497 | Comparison of early target organ damage between blacks and whites with mild systemic arterial hypertension |
| Q39937873 | Correlation of pathophysiology and pharmacotherapy in primary hypertension |
| Q41029423 | Decreased Venous Distensibility in Essential Hypertension: Lack of Systemic Hemodynamic Correlates |
| Q69700604 | Distribution of cardiac output and nutritional blood flow in the unanesthetized rat: alterations during experimental renal hypertension |
| Q43421811 | Distribution of cardiac output in different models of hypertension in the conscious rat. |
| Q85634276 | Diuretic-based regimens for obese patients? |
| Q41031428 | Does exposure to elevated levels of lead enhance sodium induced hypertension? |
| Q24538596 | Dose finding studies with imidapril--a new ACE inhibitor |
| Q68416334 | Effect of 24-hour blood pressure and heart rate variations on left ventricular hypertrophy and dilatation in essential hypertension |
| Q28334241 | Effects of carvedilol on renal function |
| Q79407442 | Essential hypertension. Haemodynamic and renal response to hypertonic sodium-chloride infusion |
| Q70352988 | Experience With Ketanserin, A Serotonin (S2) Antagonist, in Longterm Treatment of Essential Hypertension |
| Q39489047 | Factors involved in the pathogenesis of hypertensive cardiovascular hypertrophy. A review. |
| Q72570993 | Felodipine ? A new vasodilator, in addition to ?-receptor blockade in hypertension |
| Q54430084 | Genetic factors in focal segmental glomerulosclerosis. |
| Q35389861 | Heart Disease in the Hypertensive Patient |
| Q79613605 | Hemodynamic aspects of modern medical treatment of arterial hypertension |
| Q39482717 | Hemodynamic considerations in clinical hypertension |
| Q40350668 | Hemodynamic lesions in hypertension |
| Q40468273 | Hemodynamics of essential hypertension in young subjects |
| Q39695276 | ISA--vasodilatation: improvement of organ perfusion |
| Q36495555 | Impact of age, race, and obesity on hypertensive mechanisms and therapy |
| Q36128890 | Introduction: Recent perspectives on hypertension and the heart |
| Q36129308 | Is arterial pressure the sole factor responsible for hypertensive cardiac hypertrophy? |
| Q71066585 | Ketanserin in essential hypertension: effects during rest and exercise |
| Q39224298 | Labetolol—Combined Alpha and Beta Blockade for Hypertension |
| Q38634032 | Management of essential hypertension in the black patient: profiling as the initial approach to treatment |
| Q45077001 | Mathematical modeling of collagen turnover in biological tissue |
| Q35578919 | Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension |
| Q36896502 | Minoxidil in resistant hypertension |
| Q68183516 | Obesity hypertension |
| Q48597556 | Obesity in hypertension: How innocent a bystander? |
| Q69235953 | Overview. Multifactorial pathophysiological and therapeutic clinical problem |
| Q72566059 | Oxprenolol in the treatment of hypertension in the elderly |
| Q33710473 | Pathophysiologic and prognostic implications of measuring arterial compliance in hypertensive disease |
| Q39813986 | Pathophysiologic assessment of hypertensive heart disease with echocardiography |
| Q40115554 | Physiologic considerations in left ventricular hypertrophy |
| Q35569166 | RESPONSES OF THE HUMAN UPPER EXTREMITY VASCULAR BED TO EXERCISE, COLD, LEVARTERENOL, ANGIOTENSIN, HYPERTENSION, HEART FAILURE, AND RESPIRATORY TRACT INFECTION WITH FEVER |
| Q70065263 | Relationship between postoperative changes in adenosine-diphosphate induced platelet adhesiveness and venous thrombosis |
| Q69373692 | Renal and hormonal effects of alpha 1-adrenoceptor blockade by bunazosin in essential hypertension |
| Q42216979 | Similarities and differences in the antihypertensive effect of two calcium antagonist drugs, verapamil and nifedipine |
| Q66956245 | Systolic Time Intervals in Chronic Hypertension: Alterations and Response to Treatment |
| Q39978609 | The Mechanisms of Action of Antihypertensive Drugs |
| Q72222538 | The nature of the increased vascular resistance in chronic hypertension |
| Q70065266 | The vascular fault in chronic hypertension with particular reference to the role of medial hypertrophy |
| Q70722371 | Use of home-blood-pressure measurement to compare the efficacy of two diuretics. Effects of methylclothiazide and frusemide on blood pressure and plasma renin activity and electrolytes |
| Q38679740 | Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension |
| Q41511224 | [The regulation of the glomerulus filtrate and arterial blood pressure by the sodium gradients on the macula densa cells. A hypothesis on the stimulation of the renin-angiotensin system. Also a contribution on the genesis of various types of hyperte |
Search more.